A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions. (Experimental Factor Ontology, EFO_0005800)
Similar Terms
Downloads & Tools
Genes
8 genes associated with the disease substance withdrawal syndrome in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
